Table 2. Blood laboratory data and clinical responses.
PD | SD, PR | p-value a | |||
---|---|---|---|---|---|
Pre | Lymphocyte count (/μl) | <1242.3 / 1242.3≤ | 22 / 17 | 2 / 8 | 0.07 |
% lymphocyte | <20.5 / 20.5≤ | 22 /17 | 2 / 8 | 0.07 | |
NLR | <3.43 / 3.43≤ | 16 / 23 | 8 / 2 | 0.04 | |
PLR | <198.8 / 198.8≤ | 17 / 22 | 7 / 3 | 0.17 | |
MLR | <0.283 / 0.283≤ | 17 / 22 | 7 / 3 | 0.17 | |
Week 2 | Lymphocyte count (/μl) | <780.6 / 780.6≤ | 19 / 18 | 4 / 6 | 0.72 |
% lymphocyte | <14.2 / 14.2≤ | 21 / 16 | 2 / 8 | 0.07 | |
NLR | <5.18 / 5.18≤ | 15 / 22 | 8 / 2 | 0.04 | |
PLR | <272.7 / 272.7≤ | 17 / 20 | 6 / 4 | 0.49 | |
MLR | <0.442 / 0.442≤ | 16 / 21 | 7 / 3 | 0.17 |
Abbreviations: NLR, Neutrophil/Lymphocyte Ratio; PLR, Platelet/Lymphocyte Ratio; MLR, Monocyte/Lymphocyte Ratio.
a The 2-tailed Fisher’s exact probability test